Correspondence on 'Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors' by Musacchio et al.
Fatma Ferda VeritFuat DemirkiranPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)